These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24803828)

  • 21. Prevention of NSAID-induced gastroduodenal ulcers.
    Rostom A; Dube C; Wells G; Tugwell P; Welch V; Jolicoeur E; McGowan J
    Cochrane Database Syst Rev; 2002; (4):CD002296. PubMed ID: 12519573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The study of intestinal absorption and biodistribution in vivo of proton pump inhibitors.
    Shen T; Jiang X; Jin Z; Ji Q; Li C; Li Q; Long H; Qiu W; Wang W; Hou X; You J
    Eur J Pharm Biopharm; 2020 Apr; 149():135-144. PubMed ID: 32007590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of proton pump inhibitors (PPIs) plus rebamipide for endoscopic submucosal dissection-induced ulcers: a meta-analysis.
    Wang J; Guo X; Ye C; Yu S; Zhang J; Song J; Cao Z; Wang J; Liu M; Dong W
    Intern Med; 2014; 53(12):1243-8. PubMed ID: 24930641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of NSAID-induced gastroduodenal ulcers.
    Rostom A; Wells G; Tugwell P; Welch V; Dube C; McGowan J
    Cochrane Database Syst Rev; 2000; (4):CD002296. PubMed ID: 11034748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis.
    Park CH; Kim EH; Roh YH; Kim HY; Lee SK
    PLoS One; 2014; 9(11):e112558. PubMed ID: 25394217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
    Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
    Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective Single Arm Study on the Effect of Ilaprazole in Patients with Heartburn but No Reflux Esophagitis.
    Song IJ; Kim HK; Lee NK; Lee SK
    Yonsei Med J; 2018 Oct; 59(8):951-959. PubMed ID: 30187702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton pump inhibitors for preventing non-steroidal anti-inflammatory drug induced gastrointestinal toxicity: a systematic review.
    Yang M; He M; Zhao M; Zou B; Liu J; Luo LM; Li QL; He JH; Lei PG
    Curr Med Res Opin; 2017 Jun; 33(6):973-980. PubMed ID: 28076696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of CYP2C19 genetic polymorphism on pharmacokinetics and pharmacodynamics of a new proton pump inhibitor, ilaprazole.
    Cho H; Choi MK; Cho DY; Yeo CW; Jeong HE; Shon JH; Lee JY; Shin JS; Cho M; Kim DY; Shin JG
    J Clin Pharmacol; 2012 Jul; 52(7):976-84. PubMed ID: 21593280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics, Pharmacodynamics and Safety of Multiple-Infusion Ilaprazole in Healthy Chinese Subjects.
    Wang H; Lang L; Ou N; Shi R; Hu H; Hu P; Jiang J
    Clin Drug Investig; 2016 Jun; 36(6):463-70. PubMed ID: 27067231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis of the efficacy of proton pump inhibitors for the symptoms of laryngopharyngeal reflux.
    Liu C; Wang H; Liu K
    Braz J Med Biol Res; 2016 Jul; 49(7):. PubMed ID: 27383119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The eradicating Helicobacter pylori infection in duodenal ulcer patients by three short-term triple therapies in China: a multicenter clinical comparative study.
    Dai WQ; Zhou YQ; Xu L; Wang BF; Fan XM; Wu JY; Wang CY; Xu XF; Guo CY
    Hepatogastroenterology; 2012; 59(113):296-9. PubMed ID: 22260837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevention of NSAID induced gastroduodenal ulcers].
    Hansen JM; Bytzer P
    Ugeskr Laeger; 2001 Oct; 163(44):6103-5. PubMed ID: 11715151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of vonoprazan for management of post-endoscopic submucosal dissection ulcers compared with proton pump inhibitors: A meta-analysis.
    Liu C; Feng BC; Zhang Y; Li LX; Zuo XL; Li YQ
    J Dig Dis; 2019 Oct; 20(10):503-511. PubMed ID: 31414725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton pump inhibitors therapy vs H2 receptor antagonists therapy for upper gastrointestinal bleeding after endoscopy: A meta-analysis.
    Zhang YS; Li Q; He BS; Liu R; Li ZJ
    World J Gastroenterol; 2015 May; 21(20):6341-51. PubMed ID: 26034370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants.
    Green DS; Abdel-Latif ME; Jones LJ; Lui K; Osborn DA
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD011785. PubMed ID: 31265739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing intravenous and oral proton pump inhibitor therapy for bleeding peptic ulcers following endoscopic management: a systematic review and meta-analysis.
    Tringali A; Manta R; Sica M; Bassotti G; Marmo R; Mutignani M
    Br J Clin Pharmacol; 2017 Aug; 83(8):1619-1635. PubMed ID: 28181291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic drug interaction and safety after coadministration of clarithromycin, amoxicillin, and ilaprazole: a randomised, open-label, one-way crossover, two parallel sequences study.
    Jin BH; Yoo BW; Park J; Kim JH; Lee JY; Shin JS; Park MS
    Eur J Clin Pharmacol; 2018 Sep; 74(9):1149-1157. PubMed ID: 29846770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of efficacy and safety of ilaprazole and esomeprazole both in initial treatment regimen and retreatment regimen of Helicobacter pylori infection in chronic gastritis.
    Jin Y; Zhang S; Pan J; Yue M; Zhang G; Yao D; Wang Q
    Pharmazie; 2019 Jul; 74(7):432-438. PubMed ID: 31288901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.